SOUTH PLAINFIELD, N.J. (AP) _ PTC Therapeutics Inc. (PTCT) on Tuesday reported fourth-quarter net income of $1.3 million, after reporting a loss in the same period a year earlier.
On a per-share basis, the South Plainfield, New Jersey-based company said it had profit of 3 cents.
The biopharmaceutical company posted revenue of $78 million in the period.
For the year, the company reported that its loss narrowed to $79 million, or $2.02 per share. Revenue was reported as $194.4 million.
PTC Therapeutics expects full-year revenue in the range of $260 million to $295 million.
PTC Therapeutics shares have climbed 61 percent since the beginning of the year. In the final minutes of trading on Tuesday, shares hit $26.84, more than doubling in the last 12 months.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PTCT at https://www.zacks.com/ap/PTCT